Hello mil man The courts have sided already with fsd Pharma it's on AD , Zeeshan amd Dr Kotra to grow shareholder value now.
in case you missed the news arbitration didn't award raza bokhari claim.
time to move on from the negativity..
Two years from now hopefully things are better then now
clinical trials for lucid MS is where my Intrests currently lay
AD and management need to figure out how to grow shareholder value to improve stock price.
also to note , all stocks carry risks but I'm still hopeful in their value creation pipeline for the IP assets they currently hold.
waitiing on solid updates now
take care my friend